to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates

Explore clinical trials studying to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates trial results

Completed

NHFOV as Primary Support in Very Preterm Infants With RDS

NCT05141435

Conditions: to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates
Locations: Hunan Provincial Maternal and Child Health Care Hospital Changsha, Hunan, China

The Second Hospital of Shandong University Jinan, Shandong, China

Qujing Maternity and cChild Healthcare Hospital Qujing, Yunnan, China

View Trial Details